Media Releases

CAS and Kalexsyn agree to a multi-year contract to offer unlimited SciFinder® access to researchers

December  19th,   2013

Columbus, Ohio (December 19, 2013) – Chemical Abstracts Service (CAS), the world’s authority for chemical information, announced today a three-year agreement for SciFinder®, the choice for chemistry research, with Kalexsyn, a Contract Research Organization (CRO) uniquely positioned to address the needs of the pharmaceutical and biotechnology communities. Through this partnership, Kalexsyn provides unlimited searching in SciFinder for every chemist on its staff.

“There’s no other service that offers what SciFinder brings to the lab,” said Dr. Robert Gadwood, president and chief scientific officer at Kalexsyn. “The content is unmatched both in comprehensiveness and in the quality of the chemistry information accessible through SciFinder.”

Kalexsyn joins a host of other CROs that have chosen SciFinder to advance research projects. In addition to top ranking CROs globally, 47 of the top 50 pharmaceutical and biotechnology companies, and 46 of the top 50 chemical organizations around the world, rely on SciFinder to save valuable time and money by learning from previously disclosed research that is collected, organized and made discoverable by CAS.

Leaders at CROs recognize that allowing their researchers to have access to the same product their client organizations rely on gives them an advantage in the marketplace. A multi-year, unlimited agreement allows researchers at Kalexsyn to explore discovery opportunities while maintaining a predictable budget.

“We are proud to work with Kalexsyn to bring SciFinder to its researchers,” commented Chris McCue, vice president of marketing at CAS. “Whether working in medicinal chemistry, custom synthesis or process development, SciFinder supports organizations like Kalexsyn with more substance, reference and reaction information than any other single source.”

CAS Media Contact:
Rhonda Ross

Kalexsyn Media Contact:

David Zimmermann

About CAS

CAS, a division of the American Chemical Society, is dedicated to the ACS vision of improving people's lives through the transforming power of chemistry. The CAS team of highly trained scientists identifies, aggregates, and organizes all publicly disclosed chemistry information, creating the world's most valuable collection of content that is vital to innovation worldwide. Scientific researchers, patent professionals and business leaders around the world rely on a suite of research solutions from CAS that enables discovery and facilitates workflows to fuel tomorrow’s innovation.

About Kalexsyn

KALEXSYN is a world-class medicinal chemistry CRO.  Our scientists on average have 15 years each of experience in IP-enabling medicinal chemistry, structure activity relationship design, custom synthesis, stable label synthesis, early API scale-up and process improvement chemistry.  We offer clients an outstanding CRO experience with tailored short and long term contract arrangements.  Founded in 2003, Kalexsyn is located in Kalamazoo, Michigan and privately owned.  For more information about the company, please visit

Recent News

    May 22, 2017 | Wiley and CAS Announce
    Collaboration to Deliver Advanced Predictive
    Cheminformatics Capabilities to Researchers

    May 15, 2017 | CAS Powers Research for Charles
    River Laboratories and Top Contract Research
    Organizations Worldwide

    April 10, 2017 | Latest Release of New STN
    Enhances Search History and Expands Database
                                                                      More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624